nodes	percent_of_prediction	percent_of_DWPC	metapath
Naloxone—CREB1—brainstem—narcolepsy	0.0308	0.0888	CbGeAlD
Naloxone—CREB1—forebrain—narcolepsy	0.0297	0.0857	CbGeAlD
Naloxone—TLR4—brain—narcolepsy	0.028	0.0808	CbGeAlD
Naloxone—OPRD1—forebrain—narcolepsy	0.0235	0.0677	CbGeAlD
Naloxone—OPRK1—forebrain—narcolepsy	0.0225	0.0649	CbGeAlD
Naloxone—CREB1—medulla oblongata—narcolepsy	0.0215	0.0619	CbGeAlD
Naloxone—CREB1—midbrain—narcolepsy	0.0196	0.0566	CbGeAlD
Naloxone—OPRM1—brainstem—narcolepsy	0.0166	0.0479	CbGeAlD
Naloxone—OPRM1—forebrain—narcolepsy	0.016	0.0462	CbGeAlD
Naloxone—SLCO1A2—forebrain—narcolepsy	0.0138	0.0398	CbGeAlD
Naloxone—CREB1—brain—narcolepsy	0.0123	0.0356	CbGeAlD
Naloxone—ESR1—brainstem—narcolepsy	0.0121	0.0349	CbGeAlD
Naloxone—ESR1—forebrain—narcolepsy	0.0117	0.0337	CbGeAlD
Naloxone—OPRM1—midbrain—narcolepsy	0.0106	0.0305	CbGeAlD
Naloxone—SLCO1A2—medulla oblongata—narcolepsy	0.00997	0.0287	CbGeAlD
Naloxone—OPRD1—brain—narcolepsy	0.00975	0.0281	CbGeAlD
Naloxone—OPRK1—brain—narcolepsy	0.00935	0.0269	CbGeAlD
Naloxone—SLCO1A2—midbrain—narcolepsy	0.00911	0.0263	CbGeAlD
Naloxone—OPRM1—brain—narcolepsy	0.00665	0.0192	CbGeAlD
Naloxone—SLCO1A2—brain—narcolepsy	0.00573	0.0165	CbGeAlD
Naloxone—ALB—brain—narcolepsy	0.00569	0.0164	CbGeAlD
Naloxone—ESR1—brain—narcolepsy	0.00486	0.014	CbGeAlD
Naloxone—ABCB1—forebrain—narcolepsy	0.00462	0.0133	CbGeAlD
Naloxone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00432	0.00661	CbGpPWpGaD
Naloxone—OPRM1—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00426	0.00652	CbGpPWpGaD
Naloxone—OPRM1—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00426	0.00652	CbGpPWpGaD
Naloxone—OPRK1—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00417	0.00639	CbGpPWpGaD
Naloxone—CREB1—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.00415	0.00636	CbGpPWpGaD
Naloxone—OPRM1—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00411	0.0063	CbGpPWpGaD
Naloxone—TLR4—Toll-like Receptor Signaling Pathway—TNF—narcolepsy	0.00406	0.00622	CbGpPWpGaD
Naloxone—OPRD1—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00404	0.00619	CbGpPWpGaD
Naloxone—OPRK1—Peptide ligand-binding receptors—TRH—narcolepsy	0.00401	0.00614	CbGpPWpGaD
Naloxone—CYP2C8—brain—narcolepsy	0.004	0.0115	CbGeAlD
Naloxone—OPRM1—Peptide ligand-binding receptors—PENK—narcolepsy	0.00398	0.0061	CbGpPWpGaD
Naloxone—OPRK1—G alpha (i) signalling events—PENK—narcolepsy	0.00398	0.00609	CbGpPWpGaD
Naloxone—CREB1—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.0039	0.00597	CbGpPWpGaD
Naloxone—OPRD1—GPCR ligand binding—HCRTR1—narcolepsy	0.00375	0.00574	CbGpPWpGaD
Naloxone—OPRD1—GPCR ligand binding—HCRTR2—narcolepsy	0.00375	0.00574	CbGpPWpGaD
Naloxone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00365	0.00559	CbGpPWpGaD
Naloxone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00365	0.00559	CbGpPWpGaD
Naloxone—OPRD1—GPCR ligand binding—P2RY11—narcolepsy	0.00362	0.00555	CbGpPWpGaD
Naloxone—TLR4—Spinal Cord Injury—TNF—narcolepsy	0.00361	0.00553	CbGpPWpGaD
Naloxone—OPRD1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.0036	0.00552	CbGpPWpGaD
Naloxone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00355	0.00543	CbGpPWpGaD
Naloxone—OPRM1—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00352	0.0054	CbGpPWpGaD
Naloxone—OPRM1—Peptide ligand-binding receptors—TRH—narcolepsy	0.00339	0.00519	CbGpPWpGaD
Naloxone—OPRD1—G alpha (i) signalling events—HRH3—narcolepsy	0.00338	0.00518	CbGpPWpGaD
Naloxone—OPRM1—G alpha (i) signalling events—PENK—narcolepsy	0.00336	0.00515	CbGpPWpGaD
Naloxone—ABCB1—medulla oblongata—narcolepsy	0.00334	0.00963	CbGeAlD
Naloxone—OPRD1—Peptide ligand-binding receptors—TAC1—narcolepsy	0.00332	0.00508	CbGpPWpGaD
Naloxone—OPRD1—Peptide ligand-binding receptors—NPS—narcolepsy	0.00332	0.00508	CbGpPWpGaD
Naloxone—OPRK1—GPCR ligand binding—HCRTR1—narcolepsy	0.00329	0.00504	CbGpPWpGaD
Naloxone—OPRK1—GPCR ligand binding—HCRTR2—narcolepsy	0.00329	0.00504	CbGpPWpGaD
Naloxone—CREB1—Circadian rythm related genes—NPS—narcolepsy	0.00318	0.00488	CbGpPWpGaD
Naloxone—OPRK1—GPCR ligand binding—P2RY11—narcolepsy	0.00318	0.00486	CbGpPWpGaD
Naloxone—TLR4—Regulation of toll-like receptor signaling pathway—TNF—narcolepsy	0.00317	0.00485	CbGpPWpGaD
Naloxone—OPRK1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00316	0.00484	CbGpPWpGaD
Naloxone—OPRD1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00314	0.0048	CbGpPWpGaD
Naloxone—OPRD1—GPCR ligand binding—HCRT—narcolepsy	0.00308	0.00472	CbGpPWpGaD
Naloxone—OPRD1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00307	0.00469	CbGpPWpGaD
Naloxone—ABCB1—midbrain—narcolepsy	0.00305	0.0088	CbGeAlD
Naloxone—CREB1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00302	0.00462	CbGpPWpGaD
Naloxone—CREB1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00302	0.00462	CbGpPWpGaD
Naloxone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.003	0.00459	CbGpPWpGaD
Naloxone—OPRK1—G alpha (i) signalling events—HRH3—narcolepsy	0.00296	0.00454	CbGpPWpGaD
Naloxone—OPRK1—Peptide ligand-binding receptors—TAC1—narcolepsy	0.00291	0.00446	CbGpPWpGaD
Naloxone—OPRK1—Peptide ligand-binding receptors—NPS—narcolepsy	0.00291	0.00446	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00282	0.00431	CbGpPWpGaD
Naloxone—OPRM1—GPCR ligand binding—HCRTR2—narcolepsy	0.00278	0.00426	CbGpPWpGaD
Naloxone—OPRM1—GPCR ligand binding—HCRTR1—narcolepsy	0.00278	0.00426	CbGpPWpGaD
Naloxone—OPRK1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00275	0.00421	CbGpPWpGaD
Naloxone—OPRD1—GPCR ligand binding—PENK—narcolepsy	0.00275	0.0042	CbGpPWpGaD
Naloxone—OPRK1—GPCR ligand binding—HCRT—narcolepsy	0.0027	0.00414	CbGpPWpGaD
Naloxone—OPRD1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00269	0.00412	CbGpPWpGaD
Naloxone—OPRK1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00269	0.00412	CbGpPWpGaD
Naloxone—OPRM1—GPCR ligand binding—P2RY11—narcolepsy	0.00268	0.00411	CbGpPWpGaD
Naloxone—OPRM1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00267	0.00409	CbGpPWpGaD
Naloxone—OPRM1—G alpha (i) signalling events—HRH3—narcolepsy	0.00251	0.00384	CbGpPWpGaD
Naloxone—OPRM1—Peptide ligand-binding receptors—NPS—narcolepsy	0.00246	0.00377	CbGpPWpGaD
Naloxone—OPRM1—Peptide ligand-binding receptors—TAC1—narcolepsy	0.00246	0.00377	CbGpPWpGaD
Naloxone—OPRK1—GPCR ligand binding—PENK—narcolepsy	0.00241	0.00369	CbGpPWpGaD
Naloxone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00236	0.00361	CbGpPWpGaD
Naloxone—CREB1—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.00235	0.00359	CbGpPWpGaD
Naloxone—OPRD1—GPCR ligand binding—TRH—narcolepsy	0.00233	0.00357	CbGpPWpGaD
Naloxone—OPRM1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00232	0.00356	CbGpPWpGaD
Naloxone—OPRM1—GPCR ligand binding—HCRT—narcolepsy	0.00228	0.0035	CbGpPWpGaD
Naloxone—OPRM1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00227	0.00348	CbGpPWpGaD
Naloxone—CREB1—Immune System—SOCS2—narcolepsy	0.00225	0.00344	CbGpPWpGaD
Naloxone—OPRD1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00223	0.00341	CbGpPWpGaD
Naloxone—OPRD1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00223	0.00341	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00212	0.00325	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00212	0.00325	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—P2RY11—narcolepsy	0.00205	0.00313	CbGpPWpGaD
Naloxone—OPRD1—GPCR ligand binding—HRH3—narcolepsy	0.00205	0.00313	CbGpPWpGaD
Naloxone—OPRK1—GPCR ligand binding—TRH—narcolepsy	0.00205	0.00313	CbGpPWpGaD
Naloxone—OPRM1—GPCR ligand binding—PENK—narcolepsy	0.00203	0.00312	CbGpPWpGaD
Naloxone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00199	0.00305	CbGpPWpGaD
Naloxone—OPRK1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00195	0.00299	CbGpPWpGaD
Naloxone—OPRK1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00195	0.00299	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—HCRTR2—narcolepsy	0.00193	0.00296	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—HCRTR1—narcolepsy	0.00193	0.00296	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—HCRTR2—narcolepsy	0.00192	0.00295	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—HCRTR1—narcolepsy	0.00192	0.00295	CbGpPWpGaD
Naloxone—ABCB1—brain—narcolepsy	0.00192	0.00553	CbGeAlD
Naloxone—SLCO1A2—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00191	0.00293	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—P2RY11—narcolepsy	0.00186	0.00286	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—P2RY11—narcolepsy	0.00186	0.00285	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00186	0.00285	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00186	0.00285	CbGpPWpGaD
Naloxone—CREB1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00182	0.00278	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—P2RY11—narcolepsy	0.00179	0.00275	CbGpPWpGaD
Naloxone—OPRK1—GPCR ligand binding—HRH3—narcolepsy	0.00179	0.00275	CbGpPWpGaD
Naloxone—ABCB1—Allograft Rejection—HLA-DQA1—narcolepsy	0.00179	0.00275	CbGpPWpGaD
Naloxone—TLR4—Immune System—HLA-DQA1—narcolepsy	0.00176	0.00269	CbGpPWpGaD
Naloxone—ESR1—Aryl Hydrocarbon Receptor—TNF—narcolepsy	0.00176	0.00269	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—HCRT—narcolepsy	0.00174	0.00267	CbGpPWpGaD
Naloxone—OPRM1—GPCR ligand binding—TRH—narcolepsy	0.00173	0.00265	CbGpPWpGaD
Naloxone—OPRD1—GPCR ligand binding—NPS—narcolepsy	0.0017	0.0026	CbGpPWpGaD
Naloxone—OPRD1—GPCR ligand binding—TAC1—narcolepsy	0.0017	0.0026	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—HCRTR2—narcolepsy	0.00169	0.00258	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—HCRTR1—narcolepsy	0.00169	0.00258	CbGpPWpGaD
Naloxone—ABCB1—Allograft Rejection—HLA-DQB1—narcolepsy	0.00168	0.00257	CbGpPWpGaD
Naloxone—OPRM1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00165	0.00253	CbGpPWpGaD
Naloxone—OPRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00165	0.00253	CbGpPWpGaD
Naloxone—TLR4—Immune System—HLA-DQB1—narcolepsy	0.00164	0.00252	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—P2RY11—narcolepsy	0.00163	0.0025	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—HCRT—narcolepsy	0.00159	0.00243	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—HCRT—narcolepsy	0.00158	0.00242	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00157	0.00241	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00157	0.00241	CbGpPWpGaD
Naloxone—OPRD1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00156	0.00239	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—PENK—narcolepsy	0.00155	0.00238	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—HCRT—narcolepsy	0.00153	0.00234	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—P2RY11—narcolepsy	0.00152	0.00232	CbGpPWpGaD
Naloxone—OPRM1—GPCR ligand binding—HRH3—narcolepsy	0.00152	0.00232	CbGpPWpGaD
Naloxone—OPRK1—GPCR ligand binding—NPS—narcolepsy	0.00149	0.00228	CbGpPWpGaD
Naloxone—OPRK1—GPCR ligand binding—TAC1—narcolepsy	0.00149	0.00228	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—CTNNBL1—narcolepsy	0.00146	0.00224	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—HCRTR1—narcolepsy	0.00143	0.00218	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—HCRTR2—narcolepsy	0.00143	0.00218	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—PENK—narcolepsy	0.00141	0.00216	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—PENK—narcolepsy	0.00141	0.00216	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—HCRT—narcolepsy	0.00139	0.00212	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00138	0.00212	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—P2RY11—narcolepsy	0.00138	0.00211	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00138	0.00211	CbGpPWpGaD
Naloxone—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00137	0.0021	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—PENK—narcolepsy	0.00136	0.00208	CbGpPWpGaD
Naloxone—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00134	0.00205	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—TRH—narcolepsy	0.00132	0.00202	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—HCRT—narcolepsy	0.00129	0.00198	CbGpPWpGaD
Naloxone—ABCB1—Allograft Rejection—HLA-DRB1—narcolepsy	0.00127	0.00195	CbGpPWpGaD
Naloxone—OPRM1—GPCR ligand binding—NPS—narcolepsy	0.00126	0.00192	CbGpPWpGaD
Naloxone—OPRM1—GPCR ligand binding—TAC1—narcolepsy	0.00126	0.00192	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—CHKB—narcolepsy	0.00125	0.00192	CbGpPWpGaD
Naloxone—TLR4—Immune System—HLA-DRB1—narcolepsy	0.00125	0.00192	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—PENK—narcolepsy	0.00124	0.00189	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—TRH—narcolepsy	0.0012	0.00184	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—TRH—narcolepsy	0.0012	0.00183	CbGpPWpGaD
Naloxone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00117	0.0018	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—HCRT—narcolepsy	0.00117	0.00179	CbGpPWpGaD
Naloxone—CREB1—Adipogenesis—TNF—narcolepsy	0.00117	0.00179	CbGpPWpGaD
Naloxone—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00116	0.00177	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—TRH—narcolepsy	0.00116	0.00177	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—HRH3—narcolepsy	0.00116	0.00177	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—PENK—narcolepsy	0.00115	0.00176	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—HCRTR1—narcolepsy	0.00114	0.00175	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—HCRTR2—narcolepsy	0.00114	0.00175	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—HCRTR2—narcolepsy	0.00114	0.00174	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—HCRTR1—narcolepsy	0.00114	0.00174	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—P2RY11—narcolepsy	0.0011	0.00169	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—P2RY11—narcolepsy	0.0011	0.00168	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—HRH3—narcolepsy	0.00105	0.00161	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—HRH3—narcolepsy	0.00105	0.00161	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—TRH—narcolepsy	0.00105	0.00161	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—PENK—narcolepsy	0.00104	0.0016	CbGpPWpGaD
Naloxone—OPRD1—GPCR ligand binding—HTR2A—narcolepsy	0.00102	0.00156	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—HRH3—narcolepsy	0.00101	0.00155	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—HLA-DQA1—narcolepsy	0.00101	0.00155	CbGpPWpGaD
Naloxone—CREB1—SIDS Susceptibility Pathways—TNF—narcolepsy	0.00101	0.00155	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—HCRTR2—narcolepsy	0.000997	0.00153	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—HCRTR1—narcolepsy	0.000997	0.00153	CbGpPWpGaD
Naloxone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000993	0.00152	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—TRH—narcolepsy	0.000978	0.0015	CbGpPWpGaD
Naloxone—ALB—Vitamin B12 Metabolism—TNF—narcolepsy	0.000976	0.00149	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—P2RY11—narcolepsy	0.000963	0.00147	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—NPS—narcolepsy	0.000958	0.00147	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—TAC1—narcolepsy	0.000958	0.00147	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—HLA-DQB1—narcolepsy	0.000947	0.00145	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000941	0.00144	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—HCRT—narcolepsy	0.000937	0.00143	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000935	0.00143	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—HCRT—narcolepsy	0.000934	0.00143	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—HRH3—narcolepsy	0.000921	0.00141	CbGpPWpGaD
Naloxone—OPRK1—GPCR ligand binding—HTR2A—narcolepsy	0.000895	0.00137	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—TRH—narcolepsy	0.000888	0.00136	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—TAC1—narcolepsy	0.000873	0.00134	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—NPS—narcolepsy	0.000873	0.00134	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—NPS—narcolepsy	0.00087	0.00133	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—TAC1—narcolepsy	0.00087	0.00133	CbGpPWpGaD
Naloxone—CREB1—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.000858	0.00131	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—HRH3—narcolepsy	0.000857	0.00131	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—CPT1B—narcolepsy	0.000853	0.00131	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—HCRTR2—narcolepsy	0.000843	0.00129	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—HCRTR1—narcolepsy	0.000843	0.00129	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—TAC1—narcolepsy	0.00084	0.00129	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—NPS—narcolepsy	0.00084	0.00129	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—PENK—narcolepsy	0.000835	0.00128	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—PENK—narcolepsy	0.000832	0.00127	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—HCRT—narcolepsy	0.000819	0.00125	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—P2RY11—narcolepsy	0.000814	0.00125	CbGpPWpGaD
Naloxone—ALB—Folate Metabolism—TNF—narcolepsy	0.000794	0.00122	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—HRH3—narcolepsy	0.000778	0.00119	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—NPS—narcolepsy	0.000763	0.00117	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—TAC1—narcolepsy	0.000763	0.00117	CbGpPWpGaD
Naloxone—OPRM1—GPCR ligand binding—HTR2A—narcolepsy	0.000756	0.00116	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—HCRTR2—narcolepsy	0.000747	0.00114	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—HCRTR1—narcolepsy	0.000747	0.00114	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—PENK—narcolepsy	0.00073	0.00112	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—P2RY11—narcolepsy	0.000722	0.00111	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—HLA-DRB1—narcolepsy	0.00072	0.0011	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—TAC1—narcolepsy	0.00071	0.00109	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—NPS—narcolepsy	0.00071	0.00109	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—TRH—narcolepsy	0.00071	0.00109	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—TRH—narcolepsy	0.000708	0.00108	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—HCRT—narcolepsy	0.000692	0.00106	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—NPS—narcolepsy	0.000645	0.000988	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—TAC1—narcolepsy	0.000645	0.000988	CbGpPWpGaD
Naloxone—ALB—Selenium Micronutrient Network—TNF—narcolepsy	0.000631	0.000966	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—HRH3—narcolepsy	0.000622	0.000953	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—TRH—narcolepsy	0.00062	0.00095	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—HRH3—narcolepsy	0.00062	0.00095	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—PENK—narcolepsy	0.000617	0.000945	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—CHKB—narcolepsy	0.000616	0.000944	CbGpPWpGaD
Naloxone—CREB1—Immune System—HLA-DQA1—narcolepsy	0.000614	0.00094	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—HCRT—narcolepsy	0.000614	0.00094	CbGpPWpGaD
Naloxone—ALB—Metabolism—CHKB—narcolepsy	0.000613	0.000939	CbGpPWpGaD
Naloxone—ABCB1—Allograft Rejection—TNF—narcolepsy	0.000603	0.000923	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—HTR2A—narcolepsy	0.000577	0.000883	CbGpPWpGaD
Naloxone—CREB1—Immune System—HLA-DQB1—narcolepsy	0.000574	0.000879	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.000562	0.000861	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—PENK—narcolepsy	0.000547	0.000837	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—HRH3—narcolepsy	0.000544	0.000833	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—CHKB—narcolepsy	0.000537	0.000822	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—HTR2A—narcolepsy	0.000525	0.000804	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—TRH—narcolepsy	0.000524	0.000803	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—HTR2A—narcolepsy	0.000524	0.000802	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—TAC1—narcolepsy	0.000516	0.00079	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—NPS—narcolepsy	0.000516	0.00079	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—NPS—narcolepsy	0.000514	0.000787	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—TAC1—narcolepsy	0.000514	0.000787	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—HTR2A—narcolepsy	0.000506	0.000774	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—TRH—narcolepsy	0.000465	0.000712	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—HRH3—narcolepsy	0.00046	0.000704	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—HTR2A—narcolepsy	0.000459	0.000703	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—TAC1—narcolepsy	0.000451	0.00069	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—NPS—narcolepsy	0.000451	0.00069	CbGpPWpGaD
Naloxone—CREB1—Immune System—HLA-DRB1—narcolepsy	0.000437	0.000669	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—HTR2A—narcolepsy	0.000427	0.000654	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—CPT1B—narcolepsy	0.000419	0.000642	CbGpPWpGaD
Naloxone—ALB—Metabolism—CPT1B—narcolepsy	0.000417	0.000638	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—HRH3—narcolepsy	0.000408	0.000624	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—TNF—narcolepsy	0.000401	0.000614	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—HTR2A—narcolepsy	0.000388	0.000594	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—NPS—narcolepsy	0.000381	0.000584	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—TAC1—narcolepsy	0.000381	0.000584	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—CPT1B—narcolepsy	0.000365	0.000559	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—TAC1—narcolepsy	0.000338	0.000517	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—NPS—narcolepsy	0.000338	0.000517	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—CHKB—narcolepsy	0.000331	0.000507	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—HTR2A—narcolepsy	0.00031	0.000475	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—HTR2A—narcolepsy	0.000309	0.000474	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.000297	0.000455	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—HTR2A—narcolepsy	0.000271	0.000415	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—HTR2A—narcolepsy	0.000229	0.000351	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—CPT1B—narcolepsy	0.000225	0.000344	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—HTR2A—narcolepsy	0.000203	0.000311	CbGpPWpGaD
